SCHEMBL7607244

SCHEMBL7607244

Nc1cccc(C(=O)NCc2ccc(NC(=O)c3ccccc3)cc2)c1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.60
NAMPT P43490 2/20 0.58
HDAC1 Q13547 3/20 0.55
HDAC6 Q9UBN7 2/20 0.55
HDAC2 Q92769 1/20 0.55
HDAC8 Q9BY41 1/20 0.55
PPARG P37231 4/20 0.54
LMNA P02545 2/20 0.54
MAPK1 P28482 1/20 0.54
NR1H4 Q96RI1 2/20 0.53
EPHX2 P34913 1/20 0.53
SENP1 Q9P0U3 2/20 0.53
SENP5 Q96HI0 1/20 0.53
SENP2 Q9HC62 1/20 0.53
CFD P00746 1/20 0.52
MAPT P10636 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8395188 0.87 HDAC6 (0.69) HDAC1HDAC6HDAC2HDAC8PPARG
SCHEMBL11593046 0.87 PTGS1 (0.75) PTGS1HDAC1HDAC6HDAC2HDAC8
SCHEMBL7605130 0.85 PTGS1 (0.60) PTGS1HDAC1HDAC6HDAC2HDAC8
SCHEMBL7606673 0.85 EPHX2 (0.68) HDAC1HDAC6HDAC2HDAC8PPARG
Hydrochloric Acid SCHEMBL5094385 0.84 PRSS1 (0.57) NAMPTHDAC1HDAC6HDAC2HDAC8
SCHEMBL1352405 0.83 PTGS1 (0.68) PTGS1HDAC1HDAC6HDAC2HDAC8
SCHEMBL2127722 0.83 PTGS1 (0.77) PTGS1HDAC1HDAC6HDAC2HDAC8
SCHEMBL27952268 0.82 LMNA (0.70) NAMPTHDAC6HDAC2HDAC8PPARG
SCHEMBL4161846 0.82 HDAC6 (0.60) NAMPTHDAC1HDAC6HDAC2HDAC8
SCHEMBL5592556 0.81 PTGS1 (0.60) PTGS1NAMPTHDAC1HDAC2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments BOEHRINGER INGELHEIM PHARMA KG (DE) 2002-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032238-A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments MTTP, CETP, FABP1 PTGS1 361/4885NAMPT 1448/4885HDAC1 771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.